Related Experiment Video
Updated: Jul 14, 2026
07:30
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Lewis rats immunized with GM1 ganglioside do not develop peripheral neuropathy
1Department of Neurology and Neuroscience, UMDNJ-New Jersey Medical School, Newark, NJ 07652, USA. ilyasaa@umdnj.edu <ilyasaa@umdnj.edu>
Journal of Neuroimmunology
|June 15, 2007
Summary
Elevated IgM anti-GM1 antibodies, linked to motor nerve syndromes, did not cause neuropathy in rats. These findings suggest IgM anti-GM1 antibodies alone do not induce nerve damage.
Area of Science:
- Neuroimmunology
- Peripheral Neuropathy Research
Background:
- Elevated anti-GM1 antibodies are correlated with motor nerve syndromes.
- The precise pathogenic role of anti-GM1 antibodies in neuropathy remains uncertain.
Purpose of the Study:
- To investigate the role of anti-GM1 antibodies in the pathogenesis of peripheral neuropathy.
- To determine if elevated IgM anti-GM1 antibodies can induce nerve damage.
Main Methods:
- Lewis rats were immunized with GM1 ganglioside (mixed with KLH or in liposomes).
- Antibody production (IgM and IgG) and clinical signs of neuropathy were monitored for 6 months.
- Nerve pathology was assessed post-immunization.
Main Results:
- All immunized rats developed IgM anti-GM1 antibodies.
- No rats showed overt signs of neuropathy or pathological nerve damage.
- IgG anti-GM1 antibodies were not detected in any animals.
Conclusions:
- Elevated IgM anti-GM1 antibodies alone do not appear to cause peripheral neuropathy in rats.
- Further research is needed to elucidate the exact mechanisms underlying anti-GM1 antibody-associated neuropathies.
